As of 2025-07-12, the Relative Valuation of Moderna Inc (MRNA) is (102.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.64 USD, the upside of Moderna Inc based on Relative Valuation is -403.3%.
The range of the Relative Valuation is (100.90) - (104.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.9x - 12.0x | 11.0x |
| Forward P/E multiples | 11.6x - 13.2x | 12.5x |
| Fair Price | (100.90) - (104.54) | (102.02) |
| Upside | -399.9% - -410.8% | -403.3% |
| Date | P/E |
| 2025-07-10 | -3.95 |
| 2025-07-09 | -3.78 |
| 2025-07-08 | -3.75 |
| 2025-07-07 | -3.44 |
| 2025-07-03 | -3.51 |
| 2025-07-02 | -3.49 |
| 2025-07-01 | -3.30 |
| 2025-06-30 | -3.18 |
| 2025-06-27 | -3.13 |
| 2025-06-26 | -3.17 |
| 2025-06-25 | -3.09 |
| 2025-06-24 | -3.09 |
| 2025-06-23 | -2.96 |
| 2025-06-20 | -2.98 |
| 2025-06-18 | -2.93 |
| 2025-06-17 | -2.94 |
| 2025-06-16 | -2.99 |
| 2025-06-13 | -3.07 |
| 2025-06-12 | -3.15 |
| 2025-06-11 | -3.20 |
| 2025-06-10 | -3.19 |
| 2025-06-09 | -3.24 |
| 2025-06-06 | -3.16 |
| 2025-06-05 | -3.01 |
| 2025-06-04 | -3.14 |
| 2025-06-03 | -3.20 |
| 2025-06-02 | -3.12 |
| 2025-05-30 | -3.06 |
| 2025-05-29 | -3.10 |
| 2025-05-28 | -3.00 |
| 2025-05-27 | -3.08 |
| 2025-05-23 | -3.02 |
| 2025-05-22 | -3.08 |
| 2025-05-21 | -2.97 |
| 2025-05-20 | -3.22 |
| 2025-05-19 | -3.04 |
| 2025-05-16 | -2.86 |
| 2025-05-15 | -2.72 |
| 2025-05-14 | -2.77 |
| 2025-05-13 | -2.94 |
| 2025-05-12 | -2.96 |
| 2025-05-09 | -2.79 |
| 2025-05-08 | -2.81 |
| 2025-05-07 | -2.77 |
| 2025-05-06 | -2.81 |
| 2025-05-05 | -3.21 |
| 2025-05-02 | -3.18 |
| 2025-05-01 | -3.11 |
| 2025-04-30 | -3.29 |
| 2025-04-29 | -3.20 |